Company intelligence / Profile preview
Century Therapeutics
Philadelphia, Pennsylvania, United Statescenturytx.com ↗
- Ownership
- Public · IPSC
- Employees
- ~145
- Development stage
- Phase 1
01
Overview
Currently conducting CALiPSO-1 Phase 1 trial for CNTY-101 in autoimmune diseases with first patient scheduled for dosing in March 2025. Recently discontinued ELiPSE-1 trial in late-stage R/R NHL as data did not meet threshold to be considered transformational, though the company remains encouraged by clinical activity and tolerability profile. CARAMEL investigator-initiated trial expected to commence in mid-2025 following CTA approval.[5][9]
- Therapeutic areas
- OncologyImmunologyRheumatology
- Modalities
- Allogeneic iPSC-derived NK and T cell therapies
- Industry
- Biotech
02
Drug pipeline
22 assets21 more assets in the full pipeline.
03
Partnerships
Bristol Myers Squibb (research collaboration and license agreement for iPSC-derived engineered NK and T cell programs)[2]
04
Financials
- Market cap
- $273.4M
- Total revenue
- $109.2M
- Enterprise value
- $188.3M
Beyond the preview
Go deeper on Century Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Century Therapeutics.